resveratrol has been researched along with Hematologic Malignancies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espinoza, JL; Kurokawa, Y; Takami, A | 1 |
| Kawaguchi-Ihara, N; Murohashi, I; Nakamura, S; Suzuki, K; Tohda, S; Zhang, YI; Zhao, Y | 1 |
| Mihăilă, RG | 1 |
| Dicato, M; Diederich, M; Jacob, C; Kelkel, M | 1 |
| Platanias, LC; Vakana, E | 1 |
4 review(s) available for resveratrol and Hematologic Malignancies
| Article | Year |
|---|---|
Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Interactions; Hematologic Neoplasms; Herpesvirus 4, Human; Humans; Immunocompromised Host; Resveratrol; Treatment Outcome; Virus Activation | 2019 |
Could resveratrol be a useful drug for the treatment of malignant hemopathies?
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Neoplasms; Patents as Topic; Resveratrol; Stilbenes | 2014 |
Potential of the dietary antioxidants resveratrol and curcumin in prevention and treatment of hematologic malignancies.
Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Clinical Trials as Topic; Curcumin; Diet; Hematologic Neoplasms; Humans; Molecular Structure; Neoplasms; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes | 2010 |
AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.
Topics: AMP-Activated Protein Kinase Kinases; Genes, abl; Hematologic Neoplasms; Humans; Leukemia; Metformin; Phosphatidylinositol 3-Kinase; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases | 2011 |
1 other study(ies) available for resveratrol and Hematologic Malignancies
| Article | Year |
|---|---|
Chloroquine Inhibits Self-Renewal of Blast Progenitors Synergistically With Phytochemicals or Nonsteroidal Anti-inflammatory Drugs in Hematological Malignant Cell Lines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Blast Crisis; Cell Line, Tumor; Cell Self Renewal; Chloroquine; Hematologic Neoplasms; Humans; Indomethacin; Neoplastic Stem Cells; Nitrobenzenes; Phytochemicals; Resveratrol; Stem Cells; Sulfonamides; Tumor Stem Cell Assay | 2019 |